Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF  THE FINANCIAL YEAR ENDED NOVEMBER 30, 2021
Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2021
Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2021
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Dassault Systèmes and German Premium Automobile Manufacturer Develop Stamping Die Design Application for Body in White to Reduce Vehicle Development Time: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Dassault Systèmes and German Premium Automobile Manufacturer Develop Stamping Die Design Application for Body in White to Reduce Vehicle Development Time


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that it is working with the BMW Group to establish solutions to increase efficiency for vehicle development programs. With

Pharnext: The Latest Findings From CMT&Me, a ‘Real-World’ Digital Lifestyle Study on Charcot-Marie-Tooth Diseases (‘CMTs’), to be Presented at the 2022 Peripheral Nerve Society (‘PNS’) Annual Meeting
Pharnext: The Latest Findings From CMT&Me, a ‘Real-World’ Digital Lifestyle Study on Charcot-Marie-Tooth Diseases (‘CMTs’), to be Presented at the 2022 Peripheral Nerve Society (‘PNS’) Annual Meeting
Pharnext: The Latest Findings From CMT&Me, a ‘Real-World’ Digital Lifestyle Study on Charcot-Marie-Tooth Diseases (‘CMTs’), to be Presented at the 2022 Peripheral Nerve Society (‘PNS’) Annual Meeting
ALD: Trading update on Q1 2022 results
ALD: Trading update on Q1 2022 results
ALD: Trading update on Q1 2022 results
NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022


Regulatory News:



NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities

Poxel Announces Availability of Its 2021 Universal Registration Document: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces Availability of Its 2021 Universal Registration Document


POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including

ROCTOOL INNOVATES WITH THE CEA - Presentation of lightweight, 3D and eco-friendly solar panels at JEC and Intersolar
ROCTOOL INNOVATES WITH THE CEA - Presentation of lightweight, 3D and eco-friendly solar panels at JEC and Intersolar
ROCTOOL INNOVATES WITH THE CEA - Presentation of lightweight, 3D and eco-friendly solar panels at JEC and Intersolar
New Project in Latin America for NHOA: 30MWh to Support the Electrical Grid in Peru: https://mms.businesswire.com/media/20210325005370/en/867378/5/ENGIE_eps_solid_BLUE_RGB_ritagliata.jpg
New Project in Latin America for NHOA: 30MWh to Support the Electrical Grid in Peru


Regulatory News:



NHOA (NHOA.PA, formerly Engie EPS) is pleased to announce the award of a turn-key 30MWh energy storage system for ENGIE Energía Perú in Chilca, the core of Peruvian power

ESI Group stellt „Inspector"-Software auf Open-Source-Basis in Zusammenarbeit mit ENSAM bereit: https://mms.businesswire.com/media/20210510005423/de/877137/5/2020_11_04_MKTG_ESI_Logo_ColorTagline_rgb.jpg
ESI Group stellt „Inspector"-Software auf Open-Source-Basis in Zusammenarbeit mit ENSAM bereit


ESI Group (ISIN Code: FR0004110310, Mnemo: ESI), ein weltweiter Softwarepartner der Industrie für Simulation und virtuelles Prototyping, gab heute die Veröffentlichung der Open-Source-Version

ESI Group, in Collaboration With ENSAM, Deploys in Open Source Its "Inspector" Software: https://mms.businesswire.com/media/20210510005423/de/877137/5/2020_11_04_MKTG_ESI_Logo_ColorTagline_rgb.jpg
ESI Group, in Collaboration With ENSAM, Deploys in Open Source Its "Inspector" Software


Regulatory News:



ESI Group (ISIN Code: FR0004110310, Mnemo: ESI), a global simulation and virtual prototyping software partner for industry, announces the open-source release of its Inspector

New Data Featuring NANOBIOTIX Lead Product Candidate NBTXR3 to Be Presented at the 2022 ASCO Annual Meeting: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
New Data Featuring NANOBIOTIX Lead Product Candidate NBTXR3 to Be Presented at the 2022 ASCO Annual Meeting


Regulatory News:



NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the “Company”), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for

Rémy Cointreau Reaches Record Highs: https://mms.businesswire.com/media/20191127005436/en/549676/5/REMY_COINTREAU_FR_RVB.jpg
Rémy Cointreau Reaches Record Highs


Regulatory News:



Rémy Cointreau (Paris:RCO) generated revenue of €1,312.9 million in 2021-22, up +27.3% in organic terms1, including a +9.2% increase in the mix-price effect and an exceptional

Valbiotis gibt den ersten Besuch des ersten Patienten in der von der INAF1 in Partnerschaft mit Nestlé Health Science durchgeführten klinischen Studie zur Wirkungsweise von TOTUM•63 bekannt: https://mms.businesswire.com/media/20200205005659/en/689755/5/valbiotis-logo.jpg
Valbiotis gibt den ersten Besuch des ersten Patienten in der von der INAF1 in Partnerschaft mit Nestlé Health Science durchgeführten klinischen Studie zur Wirkungsweise von TOTUM•63 bekannt


Regulatorische Nachrichten:



Valbiotis (FR0013254851 - ALVAL, PEA/SME-qualifiziert), ein Forschungs- und Entwicklungsunternehmen, das sich der wissenschaftlichen Innovation zur Vorbeugung und

Valbiotis Announces the First Visit of the First Patient in the TOTUM•63 Mode of Action Clinical Study Conducted by the INAF1, in Partnership With Nestlé Health Science: https://mms.businesswire.com/media/20200205005659/en/689755/5/valbiotis-logo.jpg
Valbiotis Announces the First Visit of the First Patient in the TOTUM•63 Mode of Action Clinical Study Conducted by the INAF1, in Partnership With Nestlé Health Science


Regulatory News:



Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic and

Sensorion Announces the Publication of Its 2021 Annual Financial Report: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Announces the Publication of Its 2021 Annual Financial Report


Regulatory News:



Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and

RUBIS: Publication of the 2021 Universal Registration Document
RUBIS: Publication of the 2021 Universal Registration Document
RUBIS: Publication of the 2021 Universal Registration Document
DGAP-News: Abivax publishes Universal Registration Document 2022 'Document d'Enregistrement Universel'
DGAP-News: Abivax publishes Universal Registration Document 2022 'Document d'Enregistrement Universel'
DGAP-News: Abivax publishes Universal Registration Document 2022 'Document d'Enregistrement Universel'
Axway Software: Q1 2022 Revenue of €66.9 Million, Above Forecasts: https://mms.businesswire.com/media/20210427006220/en/800734/5/Axway_logo.jpg
Axway Software: Q1 2022 Revenue of €66.9 Million, Above Forecasts


Regulatory News:



In Q1 2022, Axway (Euronext: AXW.PA) (Paris:AXW) made a good start to the year by continuing to accelerate its move towards a business model based primarily on subscription

Sensorion Full-Year 2021 Financial Results and Business Highlights: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Full-Year 2021 Financial Results and Business Highlights


Regulatory News:



Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and

Advancing Its Digital Factory Program, Faurecia Optimizes Automated Guided Vehicle Logistics with Dassault Systèmes’ 3DEXPERIENCE Platform: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Advancing Its Digital Factory Program, Faurecia Optimizes Automated Guided Vehicle Logistics with Dassault Systèmes’ 3DEXPERIENCE Platform


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Faurecia, a company that is part of the Group Forvia, one of the largest automotive suppliers in the world, expanded

Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates
Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates
Pharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business Updates
Freelance.com: Sharp growth in results for the 2021 financial year
Freelance.com: Sharp growth in results for the 2021 financial year
Freelance.com: Sharp growth in results for the 2021 financial year
Poxel Announces Its Participation in Upcoming Scientific Conferences: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces Its Participation in Upcoming Scientific Conferences


POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including

SPAC: Postponement of the General Meeting of Shareholders
SPAC: Postponement of the General Meeting of Shareholders
SPAC: Postponement of the General Meeting of Shareholders